Glioblastoma is a aggressive brain tumor known for its rapid growth and insensitivity to typical treatments. Investigations are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is highly expressed in… Read More